Cantargia Receives Capital Injection And Attracts New Board Members

Published: Jan 15, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

STOCKHOLM--(BUSINESS WIRE)--Cantargia, a private biopharmaceutical company developing therapeutics for the treatment of leukemia, announces the conclusion of the first step in their financial plan and reinforces the board.

Help employers find you! Check out all the jobs and post your resume.

Back to news